How mobile apps are transforming health delivery – Digital Transformation News

The Covid-19 pandemic acted as a catalyst for the integration of digital technologies in healthcare; recent advances in technology are accelerating the adoption of a new trend — connected health. New offerings, such as smart medication adherence apps, mobile apps, connected rehabilitation tools, clinical decision support tools etc, will cover different phases of the healthcare experience.

Newer solutions and services help improve diagnosis and monitoring across therapeutic areas such as cardiology, oncology, mental health, diabetes and more. Bolstered by the growth prospects, life sciences organisations (medtech, biotech and pharma) are building a robust connected health portfolio. Recent findings from Capgemini Research Institute’s latest report, “The Connected Health Revolution”, reveal that life sciences firms expect more than one-fifth of revenue to come from connected health in the next five years.

The majority (63%) of life sciences organisations have connected health products already on the market . The report also found that three in five life sciences organisations are currently developing a roadmap for integrating GenAI, and over half are already piloting generative AI for interactions with patients and healthcare providers. The global connected health market is projected to grow at a CAGR of 25%, reaching around $520 billion by 2032 from $58.2 billion in 2022.

Agilus Diagnostics launches pharmacogenomics testing service in India

The Public Health Crisis We Can No Longer Ignore

Mobile apps, remote tracking are changing the face of patient care

Apple iOS 18 introduces app locking feature: Here’s how to enhance your iPhone’s security

Thorsten Rall, global life sciences industry leader at Capgemini, said, “Life sciences organisations are making real progress towards realising the potential of connected health. Unlocking the power of healthcare data and leveraging the possibilities posed by breakthrough technologies, such as GenAI, will be at the heart of this connected health revolution.”

As per the report, 21% of Indian life sciences organisations have connected health products on the market, with 44% actively testing or developing new products, and 35% strategising their approach to connected health.

Around 56% of the organisations are currently developing a roadmap for integrating GenAI and 50% of them are hiring workforces equipped with GenAI skills and building generative AI compatible IT infrastructure. For patients as well as businesses, tech-enabled care is really gaining momentum as a segment.